Clinical trial
A Study to Compare the Efficacy of Hepatitis A Vaccine and Immune Globulin When…
NCT00139139 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00139139 |
|---|---|
| Title | A Study to Compare the Efficacy of Hepatitis A Vaccine and Immune Globulin When Given After Exposure to Hepatitis A |
| Official title | A Blinded Randomized Comparative Study of Hepatitis A Vaccine and Immune Globulin for Postexposure Prophylaxis for Hepatitis A Disease |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | University of Michigan Ministry of Health, Kazakhstan |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hepatitis A |
| Intervention type | Biological |
| Interventions | Hepatitis A vaccine |
| Enrollment | 1,500 |
| Start date | Sep 1, 2003 |
| Completion | May 1, 2005 |
| First posted | Aug 31, 2005 |
| Last update posted | Jan 13, 2022 |
| Countries | Kazakhstan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: